CDK6 and glioblastoma: Consistent with our findings, the implicative role of PI3K/Akt/NF-κB/mTOR, STAT3, and CDK6 signaling pathways in the GBM phenotype, drug resistance, and poor prognoses has been well recognized in clinical and experimental studies [69,70].